Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Drug-resistant mold found to be spreading and infecting susceptible people’s lungs

by Medical Finance
in Coronavirus
Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A new study led by Imperial College London finds that drug-resistant mold is spreading from the environment and infecting susceptible people’s lungs.

The researchers found six cases of people infected with a drug-resistant form of a fungi called Aspergillus fumigatus that could be traced back to spores in the environment. Their findings use samples from England, Wales, Scotland and Ireland, and are published in Nature Microbiology.

Aspergillus fumigatus is an environmental mold that can cause fungal lung disease. While people with healthy lungs clear inhaled spores, people with lung conditions or weakened immune systems sometimes cannot, meaning the spores may remain in the lungs causing an infection called aspergillosis. Aspergillosis affects 10-20 million people worldwide. The infection is usually treated with an antifungal drug but emerging resistance to these drugs has been reported.

This resistance has evolved because of the widespread agricultural use of azole fungicides, the researchers say. Azole drugs that work in a similar way are the first-line treatment for patients infected with the Aspergillus fumigatus mold, so the fungus’ exposure to azole fungicides in the environment means it is often in a drug-resistant form even before it even encounters the people it infects.

The researchers call for greater surveillance of Aspergillus fumigatus in the environment and the clinic to help understand the risk it poses.

Senior author, Professor Matthew Fisher, from Imperial’s School of Public Health, says: “Understanding the environmental hotspots and genetic basis of evolving fungal drug resistance needs urgent attention, because resistance is compromising our ability to prevent and treat this disease.”

He adds: “The prevalence of drug-resistant aspergillosis has grown from negligible levels before 1999 to up to 3-40% of cases now across Europe. At the same time, more and more people might be susceptible to Aspergillus fumigatus infection because of growing numbers of people receiving stem cell or solid organ transplants, being on immunosuppressive therapy, or having lung conditions or severe viral respiratory infections.”

In the study, the researchers isolated 218 samples of Aspergillus fumigatus from across the England, Wales, Scotland and Ireland between 2005 and 2017. Around 7 in 10 samples were from people infected (153 samples from 143 patients in five hospitals) and the rest were from the environment (65 samples) – including from soil, compost, plant bulbs, the air and other sources.

The researchers extracted the DNA from the sample molds and sequenced it to determine whether there was crossover in the resistant spores found in the environment and in some patients.

They found six strains of Aspergillus fumigatus that existed in the environment which had infected six patients. The researchers say that the genetic similarities indicated that the fungus had spread from the environment to the patient.

Lead author, Dr Johanna Rhodes, from Imperial’s MRC Centre for Global Disease Analysis within the School of Public Health, says: “Increasingly, the cases of aspergillosis seen in the clinic are resistant to first-line azole drugs. However, we’ve not been sure how patients are acquiring these infections – whether they develop in the lungs during treatment for the infection, or whether the mold spores that infect them are drug-resistant in the first place. Our study finds that both routes of infection are possible and confirms concerns that pre-resistant mold spores in the environment are able to enter and infect people’s lungs causing harder-to-treat disease.”

Of the 218 samples, almost half (106 samples) were resistant to at least one of the first-line azole drugs used in the clinic. Specifically, 48% (104 samples) were resistant to itraconazole, 29% (64 samples) to voriconazole, and 21% to posaconazole. More than 10% of samples (26, including 23 environmental samples and 3 from patients) were resistant to two or more azole drugs.

Within the 218 samples, the researchers found 50 new genes associated with drug resistance. Looking deeper into the DNA, they also found five new combinations of single digit changes in the DNA (called single nucleotide polymorphisms, or SNPs) that were associated with drug resistance, including one which was resistant to multiple drugs.

Looking at the genes of the Aspergillus fumigatus samples, the researchers found that there were two distinct groups – group A (123 of the 218 samples) and group B (95 samples). Around 80% of samples in group A were drug resistant, while about 85% of group B were not. While the two groups were distinct, the researchers found signs of them swapping genetic material, and in some cases creating new versions of drug resistance.

The researchers say these findings indicate that the full spectrum of azole-resistance in Aspergillus fumigatus is yet to be understood.

Dr Rhodes says: “Our findings highlight new ways of resistant infections passing to people and show that a better understanding of where and how Aspergillus fumigatus is generating drug resistance is needed.”

Source:

Journal reference:

Rhodes, J., et al. (2022) Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nature Microbiology. doi.org/10.1038/s41564-022-01091-2.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Infectious disease dynamics and restrictions on social gathering size. Image Credit: View Apart/Shutterstock

Dynamics of infectious diseases and restrictions on the size of social gatherings

by Medical Finance
May 20, 2022
0

Scientists have revealed that social gatherings are one of the most likely areas where pathogen transmission could occur. Therefore,...

Study: Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Image Credit: Pormezz / Shutterstock

A common cold may boost the immune system against COVID-19

by Medical Finance
May 20, 2022
0

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at...

SARS graph

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

by Medical Finance
May 20, 2022
0

Bedford, UK | 13th January 2022 - MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM)...

Study: Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Image Credit: Michael Bihlmayer / Shutterstock.com

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, researchers compare the outcomes of the fourth and previous waves...

Study: COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Image Credit: alinabuphoto/Shutterstock

The effect of COVID-19 on routine immunizations for vaccine-preventable diseases

by Medical Finance
May 20, 2022
0

The ongoing coronavirus disease-19 (COVID-19) pandemic, caused by a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has...

Study: Persistence of endogenous SARS-CoV-2 and pepper mild mottle virus RNA in wastewater settled solids. Image Credit: NIAID

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

by Medical Finance
May 20, 2022
0

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient...

Next Post
Scientists unravel how blood cells mount the first line of defense against viruses

Genome research explains why oats could be suitable for most people with celiac disease

Swapping single food item for a more planet-friendly alternative could reduce diet’s carbon footprint

First large-scale estimate of live microbes consumed by Americans daily

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Image Credit: Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data. Image Credit: Monkey Business Images/Shutterstock
    Acute kidney injury among pediatric COVID-19 patients admitted to the ICU in North America
  • Study: Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer. Image Credit: Mircea Costina/Shutterstock
    Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply